文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

阿根廷2011-16年淋球菌ESC耐药基因组流行病学

Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

研究对阿根廷2011-16年收集的158株对广谱头孢菌素(ESC)敏感性下降或耐药的淋球菌进行全基因组测序和6种抗菌药物敏感性检测,发现50%对头孢克肟耐药、1.9%对头孢曲松耐药、37.3%对阿奇霉素耐药、63.9%为MDR表型;ESC耐药主要与mosaic penA-34.001联合mtrR启动子A缺失及PorB1b G120K/A121N突变相关,系统发育分析显示两个主要克隆群与NG-MAST ST1407相关并广泛传播。结论认为阿根廷需考虑头孢曲松联合阿奇霉素双联治疗。

要点

  • 阿根廷ESC敏感性下降/耐药淋球菌中50%对头孢克肟耐药、1.9%对头孢曲松耐药。
  • 63.9%菌株为MDR表型,37.3%对阿奇霉素耐药。
  • ESC耐药主要与mosaic penA-34.001联合mtrR启动子A缺失及PorB1b G120K/A121N相关。

核心结论

  • 阿根廷ESC敏感性下降/耐药淋球菌经一或两株菌输入后发生两次克隆扩张而快速传播,主要与国际化MDR NG-MAST ST1407克隆相关。
  • 阿根廷需考虑采用头孢曲松联合阿奇霉素双联抗菌治疗淋病。

研究设计与样本

  • 对2011-16年阿根廷各地收集的158株对ESC敏感性下降或耐药的淋球菌分离株进行WGS和6种抗菌药物敏感性检测。

主要发现

  • 50%的分离株对头孢克肟耐药,1.9%对头孢曲松耐药,37.3%对阿奇霉素耐药。
  • 63.9%的分离株显示MDR表型。
  • ESC耐药和敏感性下降主要与携带mosaic penA-34.001联合mtrR启动子A缺失及PorB1b氨基酸替换G120K/A121N的分离株相关。
  • 系统发育分析显示两个主要流行克隆群,与NG-MAST ST1407及相近STs相关,具有高流行率、广泛地理分布和时间持续性。

关键数值与推荐

  • 158株淋球菌分离株中,50%对头孢克肟耐药、1.9%对头孢曲松耐药、37.3%对阿奇霉素耐药、63.9%为MDR表型。
  • ESC耐药/敏感性下降主要与mosaic penA-34.001联合mtrR启动子A缺失及PorB1b G120K/A121N相关。
  • 主要克隆群与NG-MAST ST1407及相近STs相关。

临床怎么用

  • 在阿根廷,淋病治疗需考虑头孢曲松联合阿奇霉素双联方案。
  • 识别主要克隆的地理传播和特征有助于聚焦控制ESC耐药传播的行动计划和公共卫生政策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our aim was to describe the molecular epidemiology and antimicrobial resistance determinants of isolates of Neisseria gonorrhoeae with decreased susceptibility and resistance to extended-spectrum cephalosporins (ESCs) in Argentina in 2011-16. METHODS: Gonococcal isolates (n=158) with decreased susceptibility and resistance to ESCs collected in 2011-16 across Argentina were subjected to WGS and antimicrobial susceptibility testing for six antimicrobials. RESULTS: In total, 50% of the isolates were resistant to cefixime, 1.9% were resistant to ceftriaxone, 37.3% were resistant to azithromycin and 63.9% of the isolates showed an MDR phenotype. Resistance and decreased susceptibility to ESCs was mainly associated with isolates possessing the mosaic penA-34.001, in combination with an mtrR promoter A deletion, and PorB1b amino acid substitutions G120K/A121N. Phylogenetic analysis revealed two main clades of circulating strains, which were associated with the N. gonorrhoeae multiantigen sequence typing (NG-MAST) ST1407 and closely related STs, and characterized by a high prevalence rate, wide geographical distribution and temporal persistence. CONCLUSIONS: N. gonorrhoeae isolates with decreased susceptibility and resistance to ESCs in Argentina have emerged and rapidly spread mainly due to two clonal expansions after importation of one or two strains, which are associated with the international MDR NG-MAST ST1407 clone. The identification of the geographical dissemination and characteristics of these predominant clones may help to focus action plans and public health policies to control the spread of ESC resistance in Argentina. Dual antimicrobial therapy (ceftriaxone plus azithromycin) for gonorrhoea needs to be considered in Argentina.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Gianecini RA, Golparian D, Zittermann S, et al. Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16. J Antimicrob Chemother. 2019. PMID: 30820563. doi:10.1093/jac/dkz054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。